<b>A Phase 2 trial for those with Delta F508 is underway to test VX-770 in combination with a drug known as VX-809.</b> Like VX-770, VX-809 resulted from discovery efforts between Vertex and the CF Foundation. Laboratory studies suggest a combination of the two drugs may be more beneficial than either one alone. <b>Results of this clinical trial are expected later this year. </b>
<b>Is anyone here on this drug study??</b>
<b>Is anyone here on this drug study??</b>